![Dileep Bhagwat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dileep Bhagwat
Nessuna posizione attualmente
Storia della carriera di Dileep Bhagwat
Precedenti posizioni note di Dileep Bhagwat
Società | Posizione | Inizio | Fine |
---|---|---|---|
EpiCept Corp.
![]() EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Corporate Officer/Principal | 01/02/2004 | 15/12/2012 |
Penwest Pharmaceuticals Co.
![]() Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Direttore Tecnico/Scientifico/R&S | 01/11/1994 | 01/09/1999 |
Consigliere Generale | 01/11/1994 | 01/09/1999 | |
The Purdue Frederick Research Center | Corporate Officer/Principal | 01/11/1994 | 01/09/1999 |
Bradley Pharmaceuticals, Inc.
![]() Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Direttore Tecnico/Scientifico/R&S | 01/09/1999 | - |
Formazione di Dileep Bhagwat
St. John's University | Doctorate Degree |
Pace University | Masters Business Admin |
University of Mumbai | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
India | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Bradley Pharmaceuticals, Inc.
![]() Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Health Technology |
EpiCept Corp.
![]() EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
Penwest Pharmaceuticals Co.
![]() Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
The Purdue Frederick Research Center |
- Borsa valori
- Insiders
- Dileep Bhagwat
- Esperienza